Cancer drug resistance

A medicine commonly used to treat intestinal worm infections has caught researchers’ attention for an unexpected reason. When combined with a targeted lung cancer drug, it helped slow the growth of tumors that had stopped responding to treatment in a study involving mice. The findings, published in PLOS ONE, raise an intriguing possibility for researchers …

Cancer cells can sometimes find a way to survive the very drugs designed to stop them, leaving researchers searching for new ways to fight back. Now, scientists investigating drug-resistant lung cancer have uncovered an unexpected possibility involving mebendazole, a medicine commonly used to treat parasitic worm infections. When researchers combined it with a targeted cancer …